tiprankstipranks
Trending News
More News >
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
US Market

Cocrystal Pharma (COCP) Income Statement

Compare
1,025 Followers

Cocrystal Pharma Income Statement

Last quarter (Q3 2025), Cocrystal Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cocrystal Pharma's net income was $-2.05M. See Cocrystal Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.01M
Gross Profit
$ -12.54M$ -15.17M$ -12.39M$ -8.79M$ -4.02M
Operating Expenses
$ 5.34M$ 3.39M$ 26.44M$ 5.43M$ 5.57M
Depreciation and Amortization
$ 126.00K$ 189.00K$ 185.00K$ 190.00K$ 157.00K
EBITDA
$ -17.75M$ -20.97M$ -17.95M$ -14.03M$ -9.43M
Operating Income
$ -17.88M$ -18.56M$ -38.83M$ -14.22M$ -9.59M
Other Income/Expenses
$ 374.00K$ 575.00K$ -8.00K$ 36.00K$ -62.00K
Pretax Income
$ -17.50M$ -17.98M$ -38.84M$ -14.19M$ -9.65M
Net Income
$ -17.50M$ -17.98M$ -38.84M$ -14.19M$ -9.65M
Per Share Metrics
Basic EPS
$ -1.72$ 0.00$ -4.77$ -1.85$ -2.01
Diluted EPS
$ -1.72$ 0.00$ -4.77$ -1.85$ -2.01
Weighted Average Shares Outstanding
10.17M 9.65M 8.14M 7.69M 4.80M
Weighted Average Shares Outstanding (Diluted)
10.17M 9.65M 8.14M 7.69M 4.80M
Currency in USD

Cocrystal Pharma Earnings and Revenue History